The International Journal of Tuberculosis and Lung Disease

Measuring asthma, respiratory symptoms, and changes over time [Editorial]
pp. 1395-1395(1)
Author: David M. Mannino

The WHO/IUATLD diagnostic algorithm for tuberculosis and empiric fluoroquinolone use: potential pitfalls [Unresolved Issues]
pp. 1396-1400(5)
Author: T.R. Sterling

Indoor air pollution and airway disease [State of the Art]
pp. 1401-1415(15)
Authors: G. Viegi; M. Simoni; A. Scognamiglio; S. Baldacci; F. Pistelli; L. Carrozzi; I. Annesi-Maesano

Trends in symptoms of obstructive lung disease in Norway
pp. 1416-1422(7)
Authors: J. Brøgger; P. Bakke; G.E. Eide; B. Johansen; A.R. Andersen; A. Gulsvik

Smoking-related diseases: the importance of COPD
pp. 1423-1428(6)
Authors: C. Zaher; R. Halbert; R. Dubois; D. George; D. Nonikov

The effects of age, death period and birth cohort on asthma mortality rates in Australia
pp. 1429-1436(8)
Authors: C.J. Dobbin; J. Miller; R. van der Hoek; D.F. Baker; R. Cumming; G.B. Marks

Can BCG-vaccinated children be included in tuberculin surveys to estimate the annual risk of tuberculous infection in India?
pp. 1437-1442(6)
Authors: V.K. Chadha; P.S. Jagannatha; P. Kumar

Physician attitudes regarding bacille Calmette-Guérin vaccination and treatment of latent tuberculosis infection
pp. 1443-1447(5)
Authors: J. Salazar-Schicchi; V. Jedlovsky; A. Ajayi; P.W. Colson; Y. Hirsch-Moverman; W. El-Sadr

Molecular epidemiology of drug-resistant Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Poland: a 1-year study
pp. 1448-1457(10)
Authors: A. Sajduda; A. Brzostek; M. Popawska; N. Rastogi; C. Sola; E. Augustynowicz-Kope; Z. Zwolska; J. Dziadek; F. Portaels

Molecular epidemiology of tuberculosis in the Bata and Malabo districts of Equatorial Guinea
pp. 1458-1463(6)
Authors: G. Tudó; J. González-Martín; R. Obama; J.M. Rodríguez; J.R. Franco; M. Espasa; P.P. Simarro; G. Escaramís; C. Ascaso; A. García; M.T. Jiménez De Anta

SLC11A1 (NRAMP1) but not SLC11A2 (NRAMP2) polymorphisms are associated with susceptibility to tuberculosis in a high-incidence community in South Africa
pp. 1464-1471(8)
Authors: E.G. Hoal; L-A. Lewis; S.E. Jamieson; F. Tanzer; M. Rossouw; T. Victor; R. Hillerman; N. Beyers; J.M. Blackwell; P.D. Van Helden

Tuberculosis at Edendale Hospital in Pietermaritzburg, KwaZulu Natal, South Africa
pp. 1472-1478(7)
Authors: G.G. Alvarez; B.L. Thembela; F.J. Muller; J. Clinch; N. Singhal; D.W. Cameron

Access and adhering to tuberculosis treatment: barriers faced by patients and communities in Burkina Faso
pp. 1479-1483(5)
Authors: A. Sanou; M. Dembele; S. Theobald; J. Macq

Tuberculosis and nutrition: disease perceptions and health seeking behavior of household contacts in the Peruvian Amazon
pp. 1484-1491(8)
Authors: M.R. Baldwin; P.P. Yori; C. Ford; D.A.J. Moore; R.H. Gilman; C. Vidal; E. Ticona; C.A. Evans

Risk factors for defaulting from anti-tuberculosis treatment under directly observed treatment in Hong Kong
pp. 1492-1498(7)
Authors: K-C. Chang; C-C. Leung; C-M. Tam

The influence of risk factors on the severity of anti-tuberculosis drug-induced hepatotoxicity
pp. 1499-1505(7)
Authors: A. Fernández-Villar; B. Sopeña; J. Fernández-Villar; R. Vázquez-Gallardo; F. Ulloa; V. Leiro; M. Mosteiro; L. Piñeiro

Interpreting and reporting results [Research Methods]
pp. 1506-1509(4)
Authors: D.A. Enarson; S.M. Kennedy; D.L. Miller; P. Bakke

Correspondence
pp. 1510-1513(4)

Errata
pp. 1513-1513(1)